Panhypopituitarism
📧 Sign up to get email alerts when something new happens for Panhypopituitarism.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2026-04-03Clinical Trial Update: An Investigation of Pituitary Tumors and Related Hypothalmic Disorders
This clinical trial update notes that the NICHD study on pituitary tumors and related hypothalamic disorders is actively recruiting, coverin…
-
CLINICAL_TRIALS trial_result · 2026-01-20Clinical Trial Update: Identification and Clinical Relevance of an Oxytocin Deficient State (GLP1 Study) [Phase 4]
Phase 4 clinical trial investigating an oxytocin-deficient state and its clinical relevance in pituitary/hypothalamic disorders; the study s…
-
CLINICAL_TRIALS trial_result · 2024-04-03Clinical Trial Update: Identification and Clinical Relevance of an Oxytocin Deficient State (CRH Study) [Phase 4]
Phase 4 clinical trial investigating identification and clinical relevance of an oxytocin-deficient state in patients with hypopituitarism a…
-
CLINICAL_TRIALS trial_result · 2018-05-30Clinical Trial Update: Growth Hormone and Endothelial Function in Children [Phase 4]
Phase 4 clinical trial update from Ohio State University examining the effect of growth hormone therapy on endothelial function in children …
-
CLINICAL_TRIALS trial_result · 2017-06-27Clinical Trial Update: Testosterone Gel Applied to Women With Pituitary Gland Problems [Phase 4]
Phase 4 clinical trial evaluating testosterone gel for women with panhypopituitarism has been completed and its results were posted (2017-06…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS withdrawal · 2017-04-18Clinical Trial Update: Baseline Sexual Function, Cognitive Function, Body Composition and Muscle Parameters and Pharmacokinetics of Transdermal Testosterone Gel in Women With Hypopituitarism
A clinical trial evaluating transdermal testosterone gel in women with panhypopituitarism has been withdrawn. The study aimed to assess sexu…